Tips for searching:
• You have to select a product and type at least 2 words to activate the search
• Use only words that are specific to the information you are looking for
• Avoid typing questions or sentences
Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow card in the Google play or Apple app store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Abasaglar ® (basal insulin glargine)
This information is intended for UK registered healthcare professionals only in response to your search for information. For current information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk
Can Abasaglar® (insulin glargine) be used with COVID-19 Vaccines?
The use of vaccines against SARS-CoV-2 in patients treated with Abasaglar has not been studied.
SARS-CoV-2 Vaccination with Abasaglar
Decisions regarding the use of any vaccination, including SARS-CoV-2 vaccines, in patients treated with Abasaglar should be made at the discretion of the prescribing physician using their best clinical judgment, and must be made by the clinician after careful consideration of risk factors of the patient as well as the risks and benefits of vaccination. Consultation with an infectious disease expert may be helpful in high-risk or emergency situations such as the current COVID-19 pandemic.
What could be the impact of vaccination on blood glucose concentration?
Blood glucose levels might rise for a few days after any vaccination, according to the International Diabetes Federation (IDF).1
Resources on COVID-19 Vaccines and Diabetes
For information on COVID-19 vaccines and diabetes, please refer to
- COVID-19 and diabetes on the IDF website.1
For current information on COVID-19 and COVID-19 vaccines in general, please refer to
- Coronavirus disease (COVID-19) on the regional office EU WHO2
- COVID-19 on the ECDC website.3
References
1International Diabetes Federation Europe. Diabetes & Coronavirus Vaccination. 2021. https://idf.org/europe/news/diabetes-covid-19-vaccination-and-treatments/
2Coronavirus disease (COVID-19): vaccines and vaccine safety. World Health Organization. Updated December 5, 2023. Accessed January 4, 2024. https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines
3COVID-19. European Centre for Disease Prevention and Control. Accessed March 20, 2020. https://www.ecdc.europa.eu/en/novel-coronavirus-china
Date of Last Review: 17 December 2023